Incannex Healthcare Inc. Income Statement
IXHL|1 years of annual SEC 10-K data (FY2024-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data. All figures from audited SEC 10-K filings.
Incannex Healthcare Inc. reported $12,000 in revenue and $49M in net loss for FY2024. Its profit margin was -406758.3% in FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -10.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 |
|---|---|
| Revenue | $12.0K |
| SG&A Expense | $8.0M |
| R&D Expense | $6.3M |
| Operating Income | -$49.7M |
| Income Tax | $30.0K |
| Net Income | -$48.8M |
| EPS (Basic) | -$3.32 |
| EPS (Diluted) | -$3.32 |
| Shares Outstanding | 15.9M |
| Operating Margin | -413900.0% |
| Profit Margin | -406758.3% |